Profile data is unavailable for this security.
About the company
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
- Revenue in USD (TTM)0.00
- Net income in USD-3.58m
- Incorporated2014
- Employees12.00
- LocationRegencell Bioscience Holdings Ltd11/F First Commercial Building33-35 Leighton Roa 999077Hong KongHKG
- Phone+852 21550823
- Websitehttps://www.regencellbioscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICON PLC | 8.10bn | 599.48m | 8.27bn | 39.80k | 14.64 | 0.8857 | 8.37 | 1.02 | 7.40 | 7.40 | 101.04 | 122.25 | 0.4806 | -- | 3.00 | 193,379.50 | 3.56 | 3.70 | 4.33 | 4.46 | 28.15 | 29.00 | 7.40 | 7.41 | -- | 5.94 | 0.2675 | -- | 1.99 | 24.17 | 29.26 | 16.18 | 27.11 | -- |
| Charles River Lbrtrs ntrntl Inc | 4.02bn | -144.34m | 8.79bn | 18.30k | -- | 2.78 | 33.67 | 2.19 | -2.96 | -2.96 | 80.79 | 64.30 | 0.5477 | 9.04 | 5.62 | 219,419.80 | -1.94 | 3.42 | -2.28 | 4.01 | 34.98 | 36.22 | -3.54 | 6.37 | 1.02 | 3.43 | 0.3999 | 0.00 | -0.8545 | 6.55 | -1,501.75 | -- | 5.64 | -- |
| Vaxcyte Inc | 0.00 | -766.63m | 8.92bn | 507.00 | -- | 3.02 | -- | -- | -5.63 | -5.63 | 0.00 | 20.49 | 0.00 | -- | -- | 0.00 | -23.54 | -24.62 | -24.86 | -26.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -65.25 | -- | 118.08 | -- |
| Arrowhead Pharmaceuticals Inc | 1.09bn | 202.27m | 9.01bn | 711.00 | 41.75 | 15.55 | 34.82 | 8.26 | 1.54 | 1.54 | 7.90 | 4.14 | 0.8335 | -- | 9.86 | 1,534,432.00 | 17.84 | -25.96 | 21.44 | -30.82 | -- | -- | 21.41 | -76.01 | -- | 5.91 | 0.5068 | -- | 23,258.15 | 56.63 | 99.73 | -- | 13.66 | -- |
| BIO-TECHNE Corp | 1.22bn | 79.96m | 9.05bn | 3.10k | 113.92 | 4.48 | 49.24 | 7.44 | 0.5076 | 0.5076 | 7.74 | 12.90 | 0.4682 | 2.06 | 6.04 | 392,121.60 | 3.08 | 7.62 | 3.27 | 8.13 | 66.60 | 67.49 | 6.58 | 16.74 | 3.08 | 56.92 | 0.1145 | 26.72 | 5.23 | 10.55 | -56.35 | -20.37 | -9.74 | -4.36 |
| Praxis Precision Medicines Inc | 0.00 | -303.27m | 9.21bn | 168.00 | -- | 9.49 | -- | -- | -13.45 | -13.45 | 0.00 | 34.85 | 0.00 | -- | -- | 0.00 | -42.68 | -61.92 | -45.82 | -68.99 | -- | -- | -- | -9,004.13 | -- | -- | 0.00 | -- | -100.00 | -- | -65.88 | -- | -- | -- |
| Tempus AI Inc | 1.27bn | -245.03m | 9.53bn | 3.80k | -- | 19.34 | -- | 7.49 | -1.41 | -1.41 | 7.30 | 2.76 | 0.7946 | 10.52 | 5.46 | 334,681.30 | -15.31 | -41.14 | -19.31 | -55.06 | 62.74 | 54.59 | -19.27 | -55.73 | 3.00 | -3.90 | 0.7161 | -- | 83.41 | 46.57 | 67.17 | -- | 15.24 | -- |
| Madrigal Pharmaceuticals Inc | 958.40m | -288.28m | 9.99bn | 915.00 | -- | 16.51 | -- | 10.43 | -12.85 | -12.85 | 42.72 | 26.39 | 0.8327 | 1.03 | 10.18 | 1,047,435.00 | -25.05 | -53.85 | -31.64 | -68.43 | 94.14 | -- | -30.08 | -146.24 | 3.77 | -- | 0.3606 | -- | 432.05 | -- | 38.12 | -- | 59.68 | -- |
| Exelixis Inc | 2.32bn | 782.57m | 10.66bn | 1.08k | 14.74 | 4.98 | 13.13 | 4.59 | 2.78 | 2.78 | 8.23 | 8.23 | 0.8011 | 3.80 | 8.40 | 2,154,249.00 | 27.02 | 13.68 | 31.41 | 15.65 | 96.39 | 96.33 | 33.73 | 20.55 | 3.50 | -- | 0.00 | 0.00 | 6.98 | 18.63 | 50.13 | 47.58 | -22.60 | -- |
| Immunitybio Inc | 113.29m | -351.40m | 10.73bn | 691.00 | -- | -- | -- | 94.75 | -0.3898 | -0.3898 | 0.1232 | -0.4946 | 0.2561 | 0.164 | 5.04 | 163,947.90 | -79.44 | -101.72 | -91.74 | -204.78 | 99.34 | -- | -310.25 | -1,629.94 | 5.08 | -1.75 | 2.64 | -- | 668.31 | 184.76 | 15.03 | -- | 20.57 | -- |
| Summit Therapeutics Inc | 0.00 | -1.08bn | 12.55bn | 265.00 | -- | 19.05 | -- | -- | -1.44 | -1.44 | 0.00 | 0.8497 | 0.00 | -- | -- | 0.00 | -181.94 | -113.04 | -201.41 | -124.75 | -- | -- | -- | -82,864.48 | -- | -- | 0.00 | -- | -- | -- | -387.81 | -- | 9.31 | -- |
| Regencell Bioscience Holdings Ltd | 0.00 | -3.58m | 12.91bn | 12.00 | -- | 2,655.44 | -- | -- | -0.0073 | -0.0073 | 0.00 | 0.0098 | 0.00 | -- | -- | 0.00 | -50.50 | -53.93 | -53.75 | -65.67 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 16.68 | -- | 5.32 | -- |
| Medpace Holdings Inc | 2.53bn | 451.12m | 12.98bn | 5.90k | 29.92 | 28.20 | 27.09 | 5.13 | 15.29 | 15.29 | 85.67 | 16.22 | 1.24 | -- | 7.24 | 428,853.20 | 22.13 | 18.52 | 55.42 | 37.53 | 30.06 | 29.60 | 17.83 | 17.15 | -- | -- | 0.00 | 0.00 | 19.97 | 22.27 | 11.57 | 25.50 | 0.0102 | -- |
| Ionis Pharmaceuticals Inc | 943.71m | -381.39m | 13.54bn | 1.40k | -- | 27.37 | -- | 14.35 | -2.47 | -2.47 | 5.69 | 2.99 | 0.2892 | 1.41 | 11.93 | 673,117.00 | -11.69 | -10.64 | -14.03 | -12.40 | 98.31 | 98.40 | -40.41 | -39.12 | 3.81 | -- | 0.8266 | -- | 33.83 | 5.29 | 15.97 | -- | 7.93 | -- |
Data as of Mar 03 2026. Currency figures normalised to Regencell Bioscience Holdings Ltd's reporting currency: US Dollar USD
0.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Geode Capital Management LLCas of 31 Dec 2025 | 413.08k | 0.08% |
| Vident Advisory LLCas of 31 Dec 2025 | 29.93k | 0.01% |
| Squarepoint OPS LLCas of 31 Dec 2025 | 26.01k | 0.01% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 15.47k | 0.00% |
| XTX Markets LLCas of 31 Dec 2025 | 15.08k | 0.00% |
| Hudson Bay Capital Management LPas of 31 Dec 2025 | 13.11k | 0.00% |
| UBS Securities LLCas of 31 Dec 2025 | 12.81k | 0.00% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 5.96k | 0.00% |
| UBS Switzerland AG (Investment Management)as of 31 Dec 2025 | 5.39k | 0.00% |
| BlackRock Financial Management, Inc.as of 31 Dec 2025 | 4.87k | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
